Abstract
The pharmacokinetics and bioavailability of gentamicin sulphate (5 mg/kg body weight) were studied in 50 female broiler chickens after single intravenous (i.v.), intramuscular (i.m.), subcutaneous (s.c.) and oral administration. Blood samples were collected at time 0 (pretreatment), and at 5, 15 and 30 min and 1, 2, 4, 6, 8, 12, 24 and 48 h after drug administration. Gentamicin concentrations were determined using a microbiological assay and Bacillus subtillis ATCC 6633 as a test organism. The limit of quantification was 0.2 μg/ml. The plasma concentration–time curves were analysed using non-compartmental methods based on statistical moment theory. Following i.v. administration, the elimination half-life (t 1/2β), the mean residence time (MRT), the volume of distribution at steady state (V ss), the volume of distribution (V d,area) and the total body clearance (ClB) were 2.93 ± 0.15 h, 2.08 ± 0.12 h, 0.77 ± 0.05 L/kg, 1.68 ± 0.39 L/kg and 5.06 ± 0.21 ml/min per kg, respectively. After i.m. and s.c. dosing, the mean peak plasma concentrations (C max) were 11.37 ± 0.73 and 16.65 ± 1.36 μg/ml, achieved at a post-injection times (t max) of 0.55 ± 0.05 and 0.75 ± 0.08 h, respectively. The t 1/2β was 2.87 ± 0.44 and 3.48 ± 0.37 h, respectively after i.m. and s.c. administration. The V d,area and ClB were 1.49 ± 0.21 L/kg and 6.18 ± 0.31 ml/min per kg, respectively, after i.m. administration and were 1.43 ± 0.19 L/kg and 4.7 ± 0.33 ml/min per kg, respectively, after s.c. administration. The absolute bioavailability (F) of gentamicin after i.m. administration was lower (79%) than that after s.c. administration (100%). Substantial differences in the resultant kinetics data were obtained between i.m. and s.c. administration. The in vitro protein binding of gentamicin in chicken plasma was 6.46%.
This is a preview of subscription content, access via your institution.
Abbreviations
- AUC:
-
area under plasma concentration–time curve
- ClB :
-
total body clearance
- C max :
-
maximum plasma concentration
- t max :
-
time to peak concentration
- k el :
-
elimination rate
- V ss :
-
volume of distribution at steady state
- V d,area :
-
volume of distribution
- MRT:
-
mean residence time
- t 1/2β :
-
elimination half-life
- F :
-
absolute bioavailability
- MIC:
-
minimum inhibitory concentration
- i.v.:
-
intravenous
- i.m.:
-
intramuscular
- s.c.:
-
subcutaneous
References
Al-Amoud, A.I., Clark, B.J. and Chrystyn, H., 2002. Determination of gentamicin in urine samples after inhalation by reversed-phase high-performance liquid chromatography using pre-column derivatisation with O-phthalaldehyde. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 769, 89–95
Albarellos, G., Montoya, L., Ambros, L., Kreil, V., Hallu, R. and Rebuelto, M., 2004. Multiple once-daily dose pharmacokinetics and renal safety of gentamicin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 27, 21–25
Batra, V.K., Morrison, J.A. and Hofman, T.R., 1983. Pharmacokinetics of pipercillin and gentamicin following intravenous administration to dogs. Journal of Pharmaceutical Sciences, 72, 894–898
Bird, J.E., Miller, K.W. and Larson, A.A., 1983. Pharmacokinetics of gentamicin in birds of prey. American Journal of Veterinary Research, 44, 1245–1249
Brown, S.A. and Riviere, J.E., 1991. Comparative pharmacokinetics of aminoglycoside antibiotics. Journal of Veterinary Pharmacology and Therapeutics, 14, 1–35
Brown, S.A., Coppoc, G.L. and Riviere, J.E., 1986. Effects of dose and duration of therapy on gentamicin tissue residues in sheep. American Journal of Veterinary Research, 47, 2373–2379
Cid, D., Piriz, S. and Ruiz-Santa-Quiteria, J.A., 1996. In vitro susceptibility of Escherichia coli strains isolated from diarrhoeic lambs and goat kids to 14 antimicrobial agents. Journal of Veterinary Pharmacology and Therapeutics, 19, 397–401
Conzelman, G.M., 1980. Pharmacotherapeutics of aminoglycoside antibiotics. Journal of American Veterinary Medical Association, 176, 1078–1080
Craig, A.W. and Suh, B., 1980. Protein binding and the antibacterial effects: method for determination of protein binding. Antibiotic in Laboratory Medicine, (Williams and Wilkins, Baltimore, MD), 265–297
Drusano, G.L., 2004. Antimicrobial pharmacodynamics: critical interactions of “bug and drug”. Nature Reviews Microbiology, 2, 289–300
Frazier, D.L., Aucoin, D.P. and Riviere, J.E., 1988. Gentamicin pharmacokinetics and nephrotoxicity in naturally acquired and experimentally induced disease in dogs. Journal of American Veterinary Medical Association, 192, 57–63
Gemer, O., Zaltztein, E. and Gorodischer, R., 1983. Absorption of orally administered gentamicin in infants with diarrhea. Pediatric pharmacology, 3, 119–23
Gibaldi, M. and Perrier, D., 1982. Pharmacokinetics (Marcel Dekker, New York)
Gilbert, D.N., 1991. Once-daily aminoglycoside therapy. Antimicrobial Agents and Chemotherapy, 35, 399–405
Gunderson, B.W., Ross, G.H., Ibrahim, K.H. and Rotschafer, J.C., 2001. What do we really know about antibiotic pharmacodynamics. Pharmacotherapy, 21, 302–318
Haddad, N.S., Ravis, W.R. and Pedersoli, W.M., 1986. Pharmacokinetics of single doses of gentamicin given by intravenous and intramuscular routes to lactating cows. American Journal of Veterinary Research, 47, 808–813
Haritova, M.A., Djeneva, H.A., Lashev, L.D., Sotirova, P.G., Grov, B.I. and Dyankov, V.N., 2004. Pharmacokinetics of gentamicin and apramycin in turkeys roosters and hens in the contex of pharmacokinetic-pharmacodynamic relationships. Journal of Veterinary Pharmacology and Therapeutics, 27, 381–384
Houdeshell, J.W., Lamendola, J.F. and Mc-Cracken, J.S., 1982. Clinical pharmacology of aminoglycosides. Modern Veterinary Practice, 63, 619–621
Miranda, J.C., Schimmel, M.S, Mimms, G.M., Spinelli, W., Driscoll, J.M., James, L.S. and Rosen, T.S., 1984. Gentamicin absorption during prophylactic use for necrotizing enterocolitis. Developmental Pharmacology and Therapeutics, 7, 303–306
Pedersoli, W.M., Ravis, W.R., Askins, D.R., Krista, L.M., Spano, J.S., Whitesides, J.F. and Tolbert, D.S., 1989. Pharmacokinetics of single doses of gentamicin given intravenously and intramuscularly to turkeys. Journal of Veterinary Pharmacology and Therapeutics, 12, 124–132
Pedersoli, W.M., Ravis, W.R., Askins, D.R., Krista, L.M., Spano, J.S., Whitesides, J.F. and Tolbert, D.S., 1990. Pharmacokinetics of single-dose intravenous or intramuscular administration of gentamicin in roosters. American Journal of Veterinary Research, 5, 286–289
Riviere, J.E. and Coppoc, G.L., 1981. Pharmacokinetics of gentamicin in the juvenile dog. American Journal of Veterinary Research, 42, 1621–1623
Riviere, J.E. and Spoo J.W., 1995. Veterinary Pharmacology and Therapeutics, 7th edn, (Iowa state University Press., Ames, IA)
Tanswell, P. and Koup, J., 1993. TopFit: a PC-based pharmacokinetic/pharmacodynamic data analysis program. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 31, 514–20
Toutain, P. L. and Bousquet-Melou, A., 2004. Bioavailability and its assessment. Journal of Veterinary Pharmacology and Therapeutics, 27, 455–466
Tsai, C. and Kondo, F., 2001. Improved agar diffusion method for detecting residual antimicrobial agents. Journal of Food Protection, 64, 361–366
Wright, L.C., Horton, C.R., Jernigan, A.D., Wilson, R.C. and Clark, C.H., 1991. Pharmacokinetics of gentamicin after intravenous and subcutaneous injection in obese cats. Journal of Veterinary Pharmacology and Therapeutics, 14, 96–100.
Xiong, Y., Caillon, J. and Kerguerius, M.F., 1997. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicobial Agents and Chemotherapy, 41, 823–826
Ziv, G., Nouws, J.F. and Van-Ginneken, C.A., 1982. The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves. Journal of Veterinary Pharmacology and Therapeutics, 5, 45–58
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abu-Basha, E.A., Idkaidek, N.M. & Al-Shunnaq, A.F. Comparative Pharmacokinetics of Gentamicin after Intravenous, Intramuscular, Subcutaneous and Oral Administration in Broiler Chickens. Vet Res Commun 31, 765–773 (2007). https://doi.org/10.1007/s11259-006-3565-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11259-006-3565-0